FDA, DEA Blame Demand, Drug Makers for ADHD Med Shortage

In a letter to the public the FDA and the DEA contend that unprecedented demand, potential overprescribing, and underproduction are the primary reasons for the national shortage of stimulants to treat ADHD.
Medscape Medical News

source https://www.medscape.com/viewarticle/995079?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?